Please provide your email address to receive an email when new articles are posted on . Children aged 1 to 4 years with acute hypoxemic respiratory failure did not experience shorter hospital stays on ...

Increased respiratory patient illness, COVID-19, and product recalls have created a critical need for ventilators in the United States, said David Shockley, Movair’s CEO, in a recent company press ...

Compared to ventilator care, nasal high flow therapy for seriously ill coronavirus patients has several benefits, including the ability to mobilize patients. Nasal high flow (NHF) therapy is a less ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to the Bonhawa High Flow Oxygen Therapy system for patients with respiratory ...

Use of high-flow oxygen was associated with less of a need for mechanical ventilation and a shorter time to recovery compared with conventional oxygen therapy in patients with severe COVID-19, a ...

As the COVID-19 pandemic continues, increasing the number of patients suffering from respiratory conditions and requiring respiratory support, softFlow offers clinicians across the continuum of care ...

High-flow nasal cannula therapy is as safe and efficacious as conventional modes of noninvasive ventilation (NIV) in preterm infants, according to a meta-analysis published online August 17 and in the ...

High-flow nasal therapy (HFNT), often used for stable patients, can reduce hospital readmission for acute exacerbations for chronic obstructive pulmonary disease (COPD). High-flow nasal therapy (HFNT) ...

When patients with a tracheostomy tube reach a stage in their care at which decannulation appears to be possible, it is common practice to cap the tracheostomy tube for 24 hours to see whether they ...

Incorporating nasal high-flow therapy during endotracheal intubation attempts in the neonatal intensive care unit (NICU) increased the chance of success on the first try, a randomized study found. In ...

No benefit of high-flow therapy (HFT) can be derived from the available study data for patients with advanced chronic obstructive pulmonary disease (COPD) or chronic type 1 respiratory failure. It ...